Plexus CEO Todd Kelsey sells $393,350 in stock

Plexus Corp CEO Todd Kelsey recently sold 3,000 shares of PLXS at prices between $130.00 and $132.25, totaling $393,350, while maintaining a holding of 76,714 shares. This follows a fiscal second quarter earnings report where Plexus beat EPS estimates by $0.12 with $1.66, but slightly missed revenue forecasts at $980.17 million. Despite the revenue miss, Plexus projects a 6% year-over-year revenue increase for the fiscal third quarter and Needham analysts maintain a Buy rating, adjusting their price target to $162 from $172, citing confidence in the company's growth in aerospace, defense, and healthcare sectors.

Analysis

Plexus Corp's President and CEO, Todd Kelsey, recently divested 3,000 shares for approximately $393,350, at prices between $130.00 and $132.25, while retaining a substantial holding of 76,714 shares; such insider transactions are closely watched for executive sentiment. This activity follows Plexus's fiscal second-quarter results, where earnings per share (EPS) of $1.66 surpassed analyst expectations by $0.12, though revenues of $980.17 million narrowly missed the $981.4 million forecast. Despite the slight revenue miss, the company projects a 6% year-over-year revenue increase for the fiscal third quarter, outperforming the market's 5% growth expectation, and exhibits robust operational efficiency indicated by a perfect Piotroski Score of 9. Needham analysts reiterated a Buy rating, adjusting their price target to $162 from $172, citing confidence in Plexus's performance in aerospace, defense, and healthcare sectors. Plexus is targeting non-GAAP operating margins of 6% or higher by fiscal year 2025, driven by strategic investments in AI, automation, and capacity expansion, including a new facility in Malaysia. While the stock trades near InvestingPro’s Fair Value estimate and analyst price targets ($135-$165) suggest potential upside, InvestingPro's AI analysis did not position PLXS as a top-tier selection for massive immediate upside.

Key Decisions for Investors

• Investors should evaluate the CEO's minor share sale in the context of his significant remaining stake, the company's perfect Piotroski Score of 9, and its positive Q3 revenue guidance of 6% year-over-year.
• Consider the strong Q2 EPS beat of $0.12 and ongoing strategic initiatives, including AI investments and expansion in Malaysia, which are aimed at achieving non-GAAP operating margins of 6% or higher by FY2025, as potential catalysts for sustained growth despite a slight Q2 revenue miss.
• Assess Plexus's current valuation, trading near InvestingPro's fair value, against the analyst price target range of $135-$165 and Needham's maintained Buy rating, while also noting InvestingPro's AI assessment that PLXS may not offer exceptional near-term upside, suggesting a focus on long-term execution.